Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Shire Llc
Shire Llc_20100107
  

Shire Llc patents

Recent patent applications related to Shire Llc. Shire Llc is listed as an Agent/Assignee. Note: Shire Llc may have other listings under different names/spellings. We're not affiliated with Shire Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Shire Llc-related inventors




Date Shire Llc patents (updated weekly) - BOOKMARK this page
01/21/16Controlled dose drug delivery system
03/19/15Controlled dose drug delivery system
01/29/15Capsule and powder formulations containing lanthanum compounds
01/22/15Capsule and powder formulations containing lanthanum compounds
06/26/14Capsule and powder formulations containing lanthanum compounds
08/22/13Combination treatment of major depressive disorder
08/15/13Process for the preparation of anagrelide and analogues thereof
10/25/12Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof
07/19/12Galantamine amino acid and peptide prodrugs and uses thereof
07/12/12Prodrugs of guanfacine
06/07/12Capsule formulations containing lanthanum compounds
06/07/12Capsule and powder formulations containing lanthanum compounds
05/10/12Abuse-resistant amphetamine prodrugs
03/15/12Prodrugs of guanfacine
10/27/11Process for the preparation of anagrelide and analogues
06/23/11Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
06/02/11Substituted quinazolines as blood platelet lowering agents
06/02/11Substituted quinazolines
04/28/11Galantamine amino acid and peptide prodrugs and uses thereof
03/24/112h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
03/24/11Substituted quinazolines as blood platelet lowering agents
03/24/11Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
03/24/11Substituted quinazolines
03/17/11Substituted quinazolines
03/17/11Substituted quinazolines
03/17/11Prodrugs of guanfacine
02/24/11Pharmaceutical compositions for prevention of overdose or abuse
02/17/11Mono and di-substituted oxycodone compounds and compositions
01/13/11Abuse-resistant amphetamine prodrugs
12/02/10Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
11/11/10Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
09/09/10Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
08/05/10Abuse-resistant amphetamine prodrugs
06/10/10Compositions and methods for enhancing analgesic potency of covalently bound-compounds, attenuating its adverse side effects, and preventing their abuse
06/03/10Substituted quinazolines
04/29/10Abuse resistant lysine amphetamine compounds
01/07/10Abuse-resistant amphetamine prodrugs
12/10/09Active agent delivery systems and methods for protecting and administering active agents
10/08/09Active agent delivery protecting and administering active agents
09/17/09Abuse-resistant amphetamine prodrugs
08/20/09Abuse-resistant amphetamine prodrugs
07/30/09Abuse-resistant amphetamine prodrugs
07/30/09Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects
07/23/09Abuse-resistant amphetamine prodrugs
07/23/09Abuse-resistant amphetamine prodrugs
07/23/09Amino acid peptide pro-drugs of phenolic analgesics and uses thereof
07/23/09Abuse-resistant amphetamine prodrugs
07/16/09Abuse-resistant amphetamine prodrugs
06/11/09Abuse-resistant amphetamine prodrugs
06/04/09Abuse-resistant amphetamine prodrugs
06/04/09Abuse-resistant amphetamine prodrugs
06/04/09Abuse-resistant amphetamine prodrugs
06/04/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
Patent Packs
05/28/09Abuse-resistant amphetamine prodrugs
05/28/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
Patent Packs
05/21/09Abuse-resistant amphetamine prodrugs
05/21/09Abuse-resistant amphetamine prodrugs
05/14/09Abuse-resistant amphetamine prodrugs
05/14/09Abuse-resistant amphetamine prodrugs
05/14/09Abuse-resistant amphetamine prodrugs
02/05/09Dendritic encapsulation of active agents
01/07/10Abuse-resistant amphetamine prodrugs







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Shire Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Shire Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';